The amount of the deal was not disclosed.
Founded in 2009 as a spin-off of the Padua University’s Adaptive Optics lab by Tommaso Occhipinti, sales and marketing director, and led by Gianluigi Meneghini, CEO, Adaptica applied space and astronomy technologies to the field of ophthalmology, bringing innovations for both the measurement of refractive defects and the prescription of custom lenses.
The company will be empowered by the international scientific and business network of the new owner and it will develop new vision solutions.
The transaction was managed by Orrick Italia for Adaptica’s transferring shareholders and by Clifford Chance for the Chinese buyer group.
AliraHealth was the financial advisor of the transaction.
Among its products, there are the portable refractometer 2WIN and the portable phoropter VisionFit which allow rapid, automatic eye exams in all situations, also with non-cooperative patients. Kaleidos, Adaptica’s last creation, is a instrument that simplifies the examination by the ophtalmologist/optometrist, entertaining the patient.
The company has several patents in its portfolio and dedicates every year a large portion of its budget to research and development.